Navigation Links
UD team develops new method for producing proteins critical to medical research
Date:4/1/2010

Scientists at the University of Delaware have developed a new method for producing proteins critical to research on cancer, Alzheimer's, and other diseases.

Developed by Zhihao Zhuang, UD assistant professor of chemistry and biochemistry, and his research group, the chemical method yields hundredsfold more ubiquitylated proteins than current approaches. Such proteins may hold the key to revealing such mysteries as how cancer cells gain resistance to cancer drugs.

The advance is reported in the April issue of Nature Chemical Biology, the leading journal in the field of chemical biology. Zhuang's co-authors include graduate students Junjun Chen and Jialiang Wang and postdoctoral fellow Yongxing Ai, all from UD, and Lajos Haracska, a researcher in the Institute of Genetics at the Hungarian Academy of Sciences.

Ubiquitin is a small protein, the basis of Nobel Prize-winning research in 2004, which deemed the molecule the "kiss of death" for its role in tagging damaged or unneeded proteins for the cell's waste disposal in the constant process of protein generation and degradation. In recent years, the non-proteolytic functions of ubiquitin in diverse cellular processes, including protein trafficking, immune response, and DNA damage tolerance, have been discovered at a rapid pace, and it has become clear that ubiquitin plays far-broader roles in cell biology.

However, preparing sufficient samples of ubiquitylated proteins for study has been a major challenge facing scientists.

The availability of these proteins is critical for Zhuang and members of his research team, who are working at the interface of chemistry and biology trying to understand the molecular basis of human cancer development and prevention.

The new method for developing ubiquitylated proteins, which Zhuang and his team developed, combines the power of intein chemistry and disulfide crosslinking to bond ubiquitin to another essential protein called proliferating cell nuclear antigen.

"Our yield is hundredsfold higher compared to the commonly used enzymatic approach," Zhuang says. "We also have the flexibility of modifying the selected residues, which has not been possible with the previous approach."

In investigating the effect of the differently modified proteins, Zhuang and his group also revealed a surprising phenomenon regarding ubiquitylation.

"We found that ubiquitin as a protein modifier is far more flexible than we have thought. This property distinguishes ubiquitylation from other better studied protein post-translational modifications, such as phosphorylation and acetylation," Zhuang says.

The new UD approach will help researchers studying ubiquitin biology by providing the means to prepare milligrams of protein samples for in-depth structural and functional characterization.

SInce the publication of the work online in Nature Chemical Biology, Zhuang has received requests for samples from research groups across the United States.

Additionally, the new approach has already opened up doors to new research in Zhuang's own laboratory, where he and his team are investigating new anti-cancer therapies.


'/>"/>

Contact: Tracey Bryant
tbryant@udel.edu
302-831-8185
University of Delaware
Source:Eurekalert  

Related medicine news :

1. New York City Surgeon Develops All-Natural Treatment for Wrinkles and Scars
2. Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections
3. Nu-Tek Products Develops Cultured Soymilk Powder
4. Neuroimaging may shed light on how Alzheimers disease develops
5. Personal Best Develops Workplace Weight Loss Program
6. M. D. Anderson develops tool to measure severity of chronic graft-vs.-host disease symptoms
7. Study Finds Ponseti Method of Clubfoot Correction Leads to Lower Surgical Rates and Less Revision Surgery
8. Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods
9. Standard Methods Miss 50% of Pharmaceutical Key Opinion Leaders
10. New Web-Based MethodOne Clinic Management Software
11. Researchers discover method to objectively identify PTSD
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UD team develops new method for producing proteins critical to medical research
(Date:4/28/2017)... ... April 28, 2017 , ... Bill Howe started his sewer and drain company ... Tina Howe joined the team, the Bill Howe brand was born and they began ... and giving back to the San Diego community in which they worked, lived and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... pilot study of ActiGraph’s CentrePoint Data Hub in a sample of ... of clinical-grade wearable activity and sleep monitoring solutions for the global scientific community. ...
(Date:4/28/2017)... ... , ... Intellitec Solutions announced the publication of a case ... GP solution that integrates to their PointClickCare EHR software package. With the guidance ... Grove now has the capability to achieve its goal for a comprehensive EHR ...
(Date:4/28/2017)... ... April 28, 2017 , ... NuevaCare, a leading home care agency ... Burlingame, and Palo Alto, is proud to announce information upgrades to its blog in ... read organized content on topics such as home care (generally) as well as senior ...
(Date:4/28/2017)... ... 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer Plotting ... for fluorescence microscopists and optical system designers, enabling The Right Solution, Right Now. ... globe, SearchLight has become a tremendously popular tool for the fluorescence imaging community” ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence ... advanced Parkinson,s, according to a study released today that will ... Annual Meeting in Boston , April ... to the treatment of Parkinson,s disease, the oral drug levodopa ... life and longevity. But as the disease progresses, the effects ...
Breaking Medicine Technology: